Hero Background Image

Baron International Growth Strategy

Symbol INTLGROWTH
non
US
Non-U.S./Global

Total Strategy Assets

$321.24 M

As of 03/31/2025

Inception date

03/31/2009

Performance

PerformanceAs of 03/31/2025

Portfolio or IndexQTDYTD1 Year3 Years5 Years10 YearsSince Inception 03/31/2009
Baron International Growth Strategy (Net)-0.75%3.87%-1.11%8.66%5.82%9.46%
Baron International Growth Strategy (Gross)-0.95%4.70%-0.29%9.57%6.71%10.38%
MSCI ACWI ex USA Index-5.23%6.09%4.48%10.92%4.98%7.77%
MSCI ACWI ex USA IMI Growth Index-1.46%0.94%1.29%8.31%5.05%8.05%

Performance InformationAs of 03/31/2025

Performance statistics3 Years5 Years10 Years
Standard Deviation (%)17.6917.8916.23
Sharpe Ratio-0.310.330.24
Alpha (%)-5.51-2.790.93
Beta1.071.101.01
R-Squared (%)95.4489.6387.52
Tracking Error (%)3.935.975.74
Information Ratio-1.42-0.380.15
Upside Capture (%)94.01104.12100.96
Downside Capture (%)119.75118.9496.81
Except for Standard Deviation and Sharpe Ratio, the performance based-characteristics above were calculated relative to the Baron International Growth Strategy's benchmark MSCI ACWI ex USA IMI Growth Index. Performance statistics for additional periods will be provided on request. Source FactSet: SPAR.

Portfolio Holdings & Characteristics

HoldingsAs of 03/31/2025

HoldingSector% of Net Assets
Linde plc
Linde plc (LIN.GY) is the largest global independent industrial gas operator.
Industrial gas producers benefit from strong pricing power due to the industry's consolidated structure and high barriers to entry. We believe Linde is making a major contribution toward lowering greenhouse gas emissions and will benefit from a wave of hydrogen projects as well as carbon capture and sequestration projects, which should supplement double-digit earnings growth for the company’s base industrial gas business.
Materials3.3%
argenx SE
Argenx SE (ARGX) is a biotechnology company developing antibodies for the treatment of autoimmune disorders. The company is in the early years of the commercial launch of its drug Vyvgart (efgartigimod alfa) for a rare muscle weakness disorder.
Efgartigimod has potentially broad applicability in ameliorating overactive antibody-based diseases. Efgartigimod is a true "pipeline in a product," where the product itself is the platform, as it has the potential to be used against a diverse range of diseases—something that is rarely achieved in the biotechnology space. We expect the share price to increase as argenx proves its product’s effectiveness in multiple autoantibody disorders.
Health Care3.1%
Taiwan Semiconductor Manufacturing Company Limited
Taiwan Semiconductor Manufacturing Company Limited (2330.TT), known as TSMC, is the world's largest independent semiconductor foundry, manufacturing chips on behalf of other companies.
TSMC is the dominant force in leading-edge semiconductor foundry manufacturing, as it benefits from economies of scale and a superior cost structure. Its successful track record of deploying new technology faster than competitors enables it to maintain its market share and pricing power. We believe TSMC’s investments in advanced nodes will solidify its superior market positioning and profitability in the long run.
Information Technology3.0%
Constellation Software Inc.
Constellation Software Inc. (CSU.CN) is a holding company that owns and operates a large number of small and medium-sized software businesses. These businesses allow customers across a wide range of verticals to automate key activities with the goal of saving on labor costs.
Constellation has valuable experience to offer acquisition targets, primarily around building high-touch, low-cost modules and contract pricing. We view this experience as a durable competitive advantage while the company continues to acquire targets. With over 20,000 small owner-operated vertical market software businesses in the U.S. and Europe, Constellation's successful acquisition program and moat should remain intact. We believe management can meet its goal of compounding free cash flow per share at greater than 12% over time.
Information Technology2.9%
BNP Paribas S.A.
BNP Paribas S.A. (BNP.FP) is a French bank with leading positions in France, Belgium, and Italy. It offers retail banking, corporate investment banking, and asset management, among other financial services. BNP has smaller operations throughout Europe, as well as in the U.S., through its subsidiary Bancwest.
BNP offers a diversified earning mix, above-average execution track record, and high-quality management, in our view. It holds strong franchises in its three main activities: retail banking, corporate and institutional banking, and investment solutions, positioning it to benefit from an expected eventual recovery in the Eurozone. We think BNP will improve returns on equity (ROE) through increasing efficiencies. We also think there is upside to management’s strategic plan for achieving 10% ROE, as it is based on conservative assumptions on growth and interest rates.
Financials2.6%
Arch Capital Group Ltd.
Arch Capital Group Ltd. (ACGL) is a Bermuda-based insurance company providing property & casualty insurance, reinsurance, and mortgage insurance.
Arch is led by an experienced management team with a successful track record across insurance cycles. The company excels at underwriting specialized policies and can nimbly shift its business mix to target the most profitable lines as market conditions change. It operates in a large global market and benefits from favorable pricing trends across many of its product lines. Management has demonstrated strong underwriting discipline and capital stewardship, allowing Arch to maintain industry-leading returns on equity with less volatility.
Financials2.6%
eDreams ODIGEO SA
EDreams ODIGEO SA (EDR.SM) is one of the largest online travel companies in the world and e-commerce businesses in Europe. The company serves customers across 44 markets under four brands—eDreams, GO Voyages, Opodo, and Travellink—as well as the metasearch engine Liligo.
EDreams is transforming from a transactional to a subscription-based business and has already reached 6.8 million subscribers, ahead of its original schedule. It is on pace to reach its target of 7.25 million Prime members by fiscal year 2025, double our original forecast. The company should continue to grow through new customer acquisition and product offerings that could increase its value proposition to consumers, including through entering the fragmented European hotel market and offering more personalized and effective customer experiences with its use of AI.
Consumer Discretionary2.5%
Experian plc
Experian plc (EXPN LN) provides data and analytical tools to manage credit risk, prevent fraud, target marketing offers, and automate decision-making. The company is one of three credit bureaus in the U.S. and is the largest credit bureau in the U.K.
Experian is growing by introducing new products, entering new customer verticals, and expanding internationally. The company has aggressively expanded in developing countries by launching new credit bureaus and acquiring existing bureaus. Experian has visible revenue growth, expanding margins, and strong cash flow to fund dividends and share repurchases.
Industrials2.1%
InPost S.A.
InPost S.A. (INPST.NA) is a logistics company operating a dominant network of automated parcel lockers in Poland, with 45% market share in e-commerce delivery. It has a nascent position in the U.K. and a leading position in France through a 2021 acquisition. It also operates in several satellite countries.
InPost is driving innovation in last-mile business-to-consumer delivery. The company benefits from shared infrastructure, accelerating returns to scale and density, secular e-commerce growth, and channel shift to lockers versus to-door delivery. It holds over 90% market share in automated parcel lockers in Poland, reaching 87% of urban area residents within a seven minute walk. It is also well positioned for international expansion, leveraging cross-border opportunities and ESG advantages for merchants, customers, and regulators.
Industrials1.9%
Sumitomo Mitsui Financial Group, Inc.
Sumitomo Mitsui Financial Group, Inc. (SMFG) is the holding company for Sumitomo Mitsui Bank, one of Japan’s largest commercial banks. Through its subsidiaries, the bank offers a wide range of financial services to corporate and retail clients. The bank has over 450 branches in Japan and operations in the U.S., Europe, the Middle East and Asia.  
We believe management’s targets presented in its recent strategic plan appear conservative considering a pick-up in activity in the securities business and potential normalization of interest rate policy in Japan. The bank has been actively investing in a digital transformation, which we believe will help drive an improvement in efficiency. Lastly, management is committed to maintaining an attractive capital return profile, which should lead to a growing dividend and a potential increase to the buyback program, further enhancing returns
Financials1.9%
Total
25.8%
Top Ten Holdings, Portfolio Holdings, and Sector Breakdown based on net assets. Positions smaller than 0.05% round to 0.0%. Portfolio holdings may change over time.
Portfolio holdings are subject to change. Current and future portfolio holdings are subject to risk.

Contributors / DetractorsQuarterly as of 12/31/2024

Top ContributorsAverage WeightContribution
eDreams ODIGEO SA2.30%0.48%
Wix.com Ltd.1.71%0.43%
argenx SE2.94%0.35%
HD Hyundai Heavy Industries Co., Ltd.0.99%0.35%
Kaynes Technology India Limited0.96%0.30%
Source:  FactSet PA.  Based on the gross performance results of the representative account. 

GICS Sector BreakdownAs of 03/31/2025

Sector

Industrials

16.7%

Information Technology

15.6%

Financials

15.1%

Consumer Discretionary

12.7%

Health Care

11.0%

Materials

10.6%

Consumer Staples

7.5%

Communication Services

6.4%

Energy

3.1%

Cash & Cash Equivalents

0.8%

Real Estate

0.4%

03/31/2025
Diversified Banks9.10%
Construction Machinery & Heavy Transportation Equipment 4.60%
Application Software4.40%
Biotechnology4.20%
Semiconductors3.70%
Specialty Chemicals3.60%
Packaged Foods & Meats3.50%
Life Sciences Tools & Services3.50%
Industrial Gases3.30%
Broadline Retail 3.10%
Pharmaceuticals2.70%
Property & Casualty Insurance2.60%
Hotels, Resorts & Cruise Lines2.50%
Personal Care Products 2.40%
Movies & Entertainment2.30%
0246810
Diversified Banks9.10%
Construction Machinery & Heavy Transportation Equipment 4.60%
Application Software4.40%
Biotechnology4.20%
Semiconductors3.70%
Specialty Chemicals3.60%
Packaged Foods & Meats3.50%
Life Sciences Tools & Services3.50%
Industrial Gases3.30%
Broadline Retail 3.10%
Pharmaceuticals2.70%
Property & Casualty Insurance2.60%
Hotels, Resorts & Cruise Lines2.50%
Personal Care Products 2.40%
Movies & Entertainment2.30%
0246810
China11.30%
Japan10.30%
United Kingdom8.50%
Netherlands7.90%
India7.90%
France7.80%
Korea5.40%
Canada5.10%
Israel4.90%
United States4.10%
Spain3.90%
Germany3.40%
Taiwan3.30%
Poland2.90%
Switzerland2.20%
Sweden2.00%
Australia1.70%
Ireland1.70%
Peru1.10%
Brazil1.00%
Denmark0.80%
Italy0.80%
Greece0.50%
Hong Kong0.50%
024681012
China11.30%
Japan10.30%
United Kingdom8.50%
Netherlands7.90%
India7.90%
France7.80%
Korea5.40%
Canada5.10%
Israel4.90%
United States4.10%
Spain3.90%
Germany3.40%
Taiwan3.30%
Poland2.90%
Switzerland2.20%
Sweden2.00%
Australia1.70%
Ireland1.70%
Peru1.10%
Brazil1.00%
Denmark0.80%
Italy0.80%
Greece0.50%
Hong Kong0.50%
024681012

Portfolio CharacteristicsAs of 12/31/2024

DescriptionBaron International Growth StrategyMSCI ACWI ex USA Index
Inception DateMarch 31, 2009
# of Issuers / % of Net Assets90 / 96.4%
Turnover (3 Year Average)34.72%
Active Share85.1%
Median Market Cap$20.70 billion$10.33 billion
Weighted Average Market Cap$97.37 billion$114.29 billion
EPS Growth (3-5 year forecast)17.8%11.4%
Price/Earnings Ratio (trailing 12-month)20.615.4
Price/Book Ratio2.61.8
Price/Sales Ratio2.11.3
Total Strategy Assets$321.24 million
Price/Book Ratio and Price/Sales Ratio are calculated using the Weighted Harmonic Average. Source: FactSet PA. Internal valuation metrics may differ.